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Objective: To evaluate the interaction of articular cartilage (AC) and subchondral bone (SB) through
analysis of osteoarthritis (OA)-related genes of site-matched tissue.
Design: We developed a novel method for isolating site-matched overlying AC and underlying SB from
three and four regions of interest respectively from the human knee tibial plateau (n ¼ 50). For each site,
the severity of cartilage changes of OA were assessed histologically, and the severity of bone abnor-
malities were assessed by microcomputed tomography. An RNA isolation procedure was optimized that
yielded high quality RNA from site-matched AC and SB tibial regions. Quantitative polymerase chain
reaction (Q-PCR) analysis was performed to evaluate gene expression of 61 OA-associated genes for
correlation with cartilage integrity and bone structure parameters.
Results: A total of 27 (44%) genes were coordinately up- or down-regulated in both tissues. The
expression levels of 19 genes were statistically signiﬁcantly correlated with the severity of AC degen-
eration and changes of SB structure; these included: ADAMTS1, ASPN, BMP6, BMPER, CCL2, CCL8, COL5A1,
COL6A3, COL7A1, COL16A1, FRZB, GDF10, MMP3, OGN, OMD, POSTN, PTGES, TNFSF11 and WNT1.
Conclusions: These results provide a strategy for identifying targets whose modiﬁcation may have the
potential to ameliorate pathological alterations and progression of disease in both AC and SB simulta-
neously. In addition, this is the ﬁrst study, to our knowledge, to overcome the major difﬁculties related to
isolation of high quality RNA from site-matched joint tissues. We expect this method to facilitate
advances in our understanding of the coordinated molecular responses of the whole joint organ.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.to: M.T.M. Lee, Institute of
demia Rd., Nankang District,
-2-2782-4066.
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corresponding authors and
s Research Society International. PIntroduction
Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC), structural
changes of underlying subchondral bone (SB) and synovitis1.
Maintenance of normal joint structure and function relies on load
adaptation of the cartilage and bone. Disruption of the physiologicalublished by Elsevier Ltd. All rights reserved.
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of OA pathology2,3. Although it is debated whether skeletal adap-
tations antedate detectable alterations in the structural integrity of
the AC, numerous clinical and experimental studies have conﬁrmed
that increased bone volume and changes in bone quality of the
tibial SB of the knee are related to loss of AC integrity4e8. The
cellular system of the SB adapts rapidly in response to adverse
mechanical inﬂuences9. It also appears that factors released from
bone cells might affect cartilage metabolism10,11. These studies
provide insights into the association of mechanical load with OA
and highlight the close relationship between the SB structural
changes and alterations in AC.
Despite the fact that some of the most promising therapeutics
for OA are agents that target bone, including bisphosphonates12,13,
calcitonin14 and vitamin D15, all the gene expression studies in OA
have been performed on AC or synovium and none have been
performed on human SB tissue directly. This is most likely due to
the difﬁculties associated with isolation of RNA from SB. The SB
adheres tightly to the overlying AC and contains cells and abundant
mineralized extracellular matrix (ECM) that negatively impacts the
ability to purify RNA. For these reasons, SBmight be one of themost
difﬁcult tissues from which to extract nucleic acid.
We developed a novel method for extracting high quality
nucleic acid from bone that relies on ﬁnely grinding the desired
regions of the knee tibial plateau under liquid nitrogen. By
controlling the depth of drill penetrationwe could reliably separate
and isolate AC and site-matched SB with high ﬁdelity. We also set
up a model system based on four speciﬁc regions of interest within
a joint corresponding to a gradient of disease severities; this system
can be used to represent different disease severity states of OA.
With this method we have been able to address the goal of this
study: To understand the coordinated molecular responses of the
ACeSB unit of the OA knee. To our knowledge, this represents the
ﬁrst direct assessment of gene expression in OA of site-matched AC
and SB.Fig. 1. Custom tools for joint tissue sectioning and sites of analysis and regions fo
components: (1) a rotary tool holder, (2) a high speed rotary motor, (3) custom adapter, (4
grinding tissue. (b) Joint tissue bathed in liquid nitrogen (LN) ready for sectioning. (c) H
histological analysis at the four regions of interest; the dashed boxes demonstrate regions fo
(f) inner medial tibial plateau (iMT); and the central medial tibial plateau (cMT) devoid of car
locations chosen. Masson stained photomicrographs of AC (left) and site-matched SB (right)
thick, 25 mm diameter.Materials and methods
Human knee joint tissues
Human tibial plateaus were obtained during total knee joint
replacement surgery from 50 patients with medial compartment
knee OA, comprising 32 females and 18 males (mean age 69 years,
range 51e91 years). To ensure consistency of sampling of pre-
speciﬁed regions of interest, the anatomic orientation was indi-
cated on the freshly isolated specimens by marker pen then all
specimens were stored immediately in liquid nitrogen. The study
was approved by the institutional review board of all the partici-
pating hospitals and Academia Sinica, Taiwan, and written
informed consent was obtained from all of the participants.
Regions of interest
The regions of interest chosen for this study were informed by
prior work of Appleyard16 and our preliminary analyses of 26
regions of three human tibial plateau specimens (Supplementary
Fig. 1). We were able to reduce our analyses to four speciﬁc
regions encompassing a full range of histological severity in knee
OA specimens: (1) the outer region of the lateral tibial plateau (oLT,
excluding adjacent ﬁbrocartilage) with a visibly smooth AC surface
[Fig. 1(d) and regions 2 þ 3 in Appleyard’s study]; (2) the inner
lateral tibial plateau (iLT) with sufﬁcient AC to detect visible ﬁssures
on tissue crossection [Fig. 1(e) and regions 10 þ 11 in Appleyard’s
study]; (3) the inner medial tibial plateau (iMT), a region on the
inner side of the MT with visible loss of AC [Fig. 1(f) and regions
16 þ 17þ20 þ 21 in Appleyard’s study]; (4) the central medial tibial
plateau (cMT), the central region of the MT with near full thickness
loss of AC [Fig. 1(f) and regions 20 þ 21þ24 þ 25 in Appleyard’s
study]. Regions of interest were w2 mm in width, w2e4 cm in
length, and w5 mm in height. If regions of the tibial plateau were
too small to section or too thin to analyze, these regions werer RNA isolation. (a) The workstation was constructed from commercially available
) a 90 Angle Adaptor and (5) a 25 mm diameter cutting disc of 0.1 mm thickness for
uman osteoarthritic knee tibial plateau; the red boxes indicate regions for mCT and
r RNA isolation: (d) outer lateral tibial plateau (oLT); (e) inner lateral tibial plateau (iLT);
tilage. Osteophytes were not included in the sampling by the nature of the prespeciﬁed
from the following regions: (g) oLT, (h) iLT, (i) iMT and (j) cMT. (k) Cutting discs, 0.1 mm
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could be tested, but only 38 of 50 iMT and 36 of 50 cMT regions had
sufﬁcient cartilage and bone for sample analysis.
Joint tissue sectioning
The workstation, used to section regions of interest from the
isolated tibial plateaus, was constructed primarily from commer-
cially available components: a rotary tool holder (PROXXON,
no28606, Germany); a high speed rotarymotor (PROXXON, no38481,
Germany), custom adapter (Academia Sinica, Taiwan), a 90 Angle
Adaptor (PROXXON, no28405, Germany) [Fig. 1(a)]; and a 25 mm
diameter cutting disc of 0.1 mm thickness for grinding tissue (Busch,
S606025s, Germany) [Fig. 1(k)]. Tissues were sectioned to generate
2mmthick slicesof intact cartilageandattachedbone fromregionsof
interest for histology as well as adjacent regions for subsequent
grinding and RNA isolation. To prevent RNA degradation, and to
precisely obtain specimens of a particular type from speciﬁc regions
of interest of the joint, the tissues were manipulated at all times
under liquid nitrogen in a thermally insulated styrofoam container
[Fig. 1(b)]. Three 2e2.5 mm-thick osteochondral slabs were gener-
ated for further microcomputed tomography (mCT) scanning and
histological staining [Fig. 1(c)].
Tissue grinding
After trimming specimens under liquid nitrogen, longitudinal
sections of the tibial plateaus were exposed. Cartilage (white
coloration) and SB (pink coloration) could be observed. To harvest
specimens of overlying AC separately from the underling SB, the
high speed rotary tool was carefully lowered onto the cartilage
surface and grinding was carried out in a mortar ﬁlled with liquid
nitrogen (to prevent RNA degradation) until the SB boundary was
reached. The ground cartilage powder that sank to the bottom of
the mortar was carefully decanted into a 50 ml tube. The same
procedure was performed for the SB. The ground tissue powders
from the AC and SB were stored in 80C until RNA extraction. The
absence of heat generation while grinding under liquid nitrogen
was conﬁrmed by thermal imaging (Fig. 2).
RNA extraction
RNA was isolated from the four prespeciﬁed regions of interest
for eight individual specimens; these eight specimens were chosen
on the basis of having a gradient of lesion severity across the tibial
plateau and adequate amounts of bone and cartilage tissue from
each of the regions for RNA isolation. These eight subjects were
representative of the whole sample set (overall similar mean age of
68 years and similar gender distribution with 38% male). Approx-
imately 100 mg of powdered AC or SB from each region of interest
was obtained for RNA extraction. 5 ml of Trizol (Invitrogen, CA)
were added to 100 mg (dry weight) of the ground tissue powder
and mixed by vortexing until homogeneous. The remaining
protocol is described in Supplementary protocol. The RNA
concentration and purity were determined by a Nano-Drop
(NanoDrop Technologies, DE). The RNA integrity number (RIN)
and 28S/18S ratio were estimated using the RNA 6000 Nano Assays
on an Agilent 2100 Bioanalyzer (Agilent Technologies, CA).
Histological scoring of cartilage and bone
Adjacent to the regions ground for RNA, we obtained cartilagee
bone sections of approximately 2 mm diameter from the tibial
plateau for histological and bone structure evaluation of all 50
specimens. Sections were ﬁxed in 4% paraformaldehyde (4% PFA)(SigmaeAldrich, Mo) overnight and decalciﬁed in 10% ethylenedi-
amine-N,N,N0,N0-tetra-acetic acid, disodium salt, dehydrate
(EDTA2Na) (SigmaeAldrich, Mo) for 2 weeks. After decalciﬁcation,
the sections were embedded in parafﬁn and 10 mm sections were
prepared, then deparafﬁnized, hydrated and treated with Masson’s
trichrome stain according to the manufacturer’s instructions
(SigmaeAldrich, Mo).
Digital images of each section were acquired at 200 magniﬁ-
cation using a Mirax Scan (Carl Zeiss, Germany). After routine
histological processing, sections were scored on a six level histo-
pathological grading scale (G1-6) and a ﬁve level staging scale (S0-
4) based on the Osteoarthritis Research Society International
(OARSI) OA Cartilage Histopathology Assessment System17; the
overall score was computed as the product of the grade and stage.
Two graders performed the assessments, blinded to the topo-
graphical origin of each slide. They scored three consecutive
sections of every speciﬁc region of the OA tibial plateau; the results
were averaged to achieve a ﬁnal OARSI histopathological score for
each joint site of each joint (possible range 0e24).
mCT
Regions of interest were sectioned from the tibial plateau
extending from the surface to the subarticular tissue beneath the
calciﬁed cartilage (w2 mm width, 2w4 cm length, and w5 mm
height). The sections were ﬁxed in 4% PFA overnight at 4C then
scanned in a high performance mCT scanner, SKYSCAN 1076 (SKY-
SCAN, Belgium) at a resolution of 18 mm. After scanning, the bone
mineral density (BMD) was determined for a volume of interest
(w2 mm width,w5 mm length, andw5 mm height) using the CT
Analyser software (SKYSCAN, Kontich, Belgium). Three-
dimensional reconstruction was performed to obtain the bone
structural parameters that included the following: percent bone
volume (BV/TV; %); the structure model index (SMI); trabecular
thickness (Tb.Th; mm); trabecular number (Tb.N; mm1); and
trabecular separation (Tb.Sp; mm). SMI is an estimation of the
plate-like or rod-like (cylindrical) characteristics of the SB struc-
ture. The ideal plate and cylindrical architectures have SMI values of
0 and 3 respectively18. A rod-like trabecular bone structure has
higher mechanical strength than a plate-like structure19.
Real-time quantitative PCR
A total of 1600 ng RNA from each section was converted into
cDNA using Superscript III reverse transcriptase (Invitrogen, CA). A
total of 64 genes were selected for gene expression analysis
(Supplementary Table 1). Gene expressionwas determined by real-
time quantitative PCR (Q-PCR) using the TaqMan high density
microﬂuidic cards (Invitrogen, CA) according to the manufacturer’s
instructions. The Q-PCR reactions were performed on the ABI Prism
7900HT Sequence Detection system and the ﬂuorescent signal
intensity was analyzed by Sequence Detector v2.3 software. The
levels of cDNA among samples were normalized to the expression
of GAPDH ﬁrst and the DDCt relative quantiﬁcation method for
calculating gene expression was then applied.
Statistical analysis
The normality of all the measures has been tested by the
KolmogoroveSmirnov test (Graphpad Prism v5.0, San Deigo, CA);
this revealed that all parameters were normally distributed with
the exception of BMDwhich violated this assumption for a very few
of the regions studied (Supplementary Table 2). One-way analysis
of variance was used to determine differences among regions with
respect to tibial OARSI scores, BV/TV, SMI, Tb.Th, Tb.N, and Tb.Sp. To
Fig. 2. Sectioning and grinding methods for separating overlying AC and underlying SB. (a and b) The custom-made mini bone saw workstation was utilized to section regions
of interest in liquid nitrogen. (c) Tissue elements could be clearly distinguished consisting of white overlying AC and light pink/yellow underlying SB. (d) The black arrow depicts
a region from which cartilage has been ground off by the high speed rotary grinder. (e) Site-matched SB subsequently ground off below the corresponding overlying AC. (f) An
example of the powdered tissue collected by decanting the liquid N2 into a tube for further manipulation. (gei) Masson staining was performed to illustrate the stages of the
procedure through histologic examination of the tissue. Cartilage was stained with blue color and bone was stained with red color. Original magniﬁcation 10. (j) The entire process
was performed in liquid nitrogen and was carried out below 30C. (k) Minimal heat was generated by the drilling procedure as demonstrated by thermal imaging. (l) Wolfram
vanadium steel milling bits for precision grinding, Ø 2.35 mm. (m) Carbon ﬁber tweezers with low temperature resistance used to stabilize samples during manipulation.
C.-H. Chou et al. / Osteoarthritis and Cartilage 21 (2013) 450e461 453control for type I error, the Bonferroni multiple comparison test
was performed as a post-hoc analysis to determine the statistical
signiﬁcance of changes in cartilage integrity and bone parameter
between regions. BMD data were analyzed with non-parametric
KruskaleWallis test and Dunn’s post-hoc test. Student’s t tests
were used to assess differences in the means levels of expression
for each gene between iLT, iMT, and cMT regions relative to the oLT
region. Correlation between the histologic scores of the cartilage,
site-matched bone parameters, and real-time PCR determined gene
expressionwas calculated using Pearson correlation. P value < 0.05
was considered statistically signiﬁcant.Results
Model system
Histologic evaluation using the OARSI scoring system veriﬁed
that cartilage pathology varied in severity by location. The greatest
pathological changes occurred at the cMT region where there wascomplete cartilage loss and denuded sclerotic bone [Fig. 1(f and j)].
For the other regions, we observed the following histological
ﬁndings: superﬁcial zone delamination and mid layer cyst forma-
tion at iMT regions [Fig. 1(f and i)]; branched ﬁssures of matrix and
disorientation of chondron columns at iLT regions [Fig. 1(e and h)];
and predominantly an intact or only mildly ﬁbrillated superﬁcial
zone in oLT regions [Fig. 1(d and g)]. Histological analysis indicated
that cMT, iMT, and even the nearby iLT regions of each specimen
had signiﬁcantly more severe cartilage pathological changes than
the oLT regions (P < 0.001) (Table I).Structural parameters of the SB
In our system, SB referred to the total subarticular tissue under
the calciﬁed cartilage, which included the SB plate and subarticular
spongiosa and extended to 2e5 mm depth depending on the indi-
vidual specimen. The structure of the SB in the four regions was
analyzed by mCT. The pathological changes in the bonewere striking
for their incremental and orderly step-wise progression beginning
Table I
Characteristics of the overlying AC and underlying SB by region of interest in the human knee tibial plateau [mean  standard deviation (SD)]
Characteristics oLT iLT iMT cMT
OARSI 5.24  2.02 12  3.04 17.5  1.45 21.9  0.49
BV/TV, (%) 22.9  4.5 33.5  8.81 61  14.5 67.8  12.5
SMI 1.59  0.39 1.22  0.61 0.79  1.32 2.21  2.03
Tb.Th, (mm) 0.21  0.04 0.28  0.05 0.35  0.07 0.4  0.09
Tb.N, (1/mm) 1.11  0.2 1.22  0.24 1.75  0.26 1.73  0.27
Tb.Sp, (mm) 0.5  0.08 0.46  0.12 0.28  0.1 0.25  0.09
BMD, (gm/cm3) 1  0.06 1.05  0.07 1.08  0.08 1.08  0.09
Age, (years) 69.9  7.75 70.7  7.87 70.7  7.26 70.8  7.6
Numbers 50 50 38 36
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(cMT). The oLT regionswere distinctly different from the other three
regions and distinguished by the following characteristics: the
lowest BV/TV; a rod-like trabecular architecture; the thinnest and
least trabecular bone; the highest Tb.Sp; and the lowest bone
density. The iMTand cMT regions had predominantly sclerotic bone
features compared to the oLT and iLT regions; in addition, the iMT
and cMT regions had a higher bone volume, and a plate-like struc-
ture with thicker, denser and more abundant trabecular bone
(Table I and Fig. 3). There were no statistically signiﬁcant gender
differences for any parameter (Supplementary Table 3).Correlation between underlying SB features and overlying cartilage
degeneration
The severity of AC degeneration, as assessed by OARSI scores,
was signiﬁcantly correlated with BV/TV (r ¼ 0.83, P < 0.001), Tb.Th
(r ¼ 0.75, P < 0.001), Tb.N (r ¼ 0.68, P < 0.001), and BMD (r ¼ 0.42,
P < 0.001) [Fig. 2(a, c, d, f)], and inversely correlated with SMI
(r ¼ 0.7, P < 0.001) and Tb.Sp (r ¼ 0.7, P < 0.001) (Fig. 4). In
addition, BV/TV represented the highest correlation with the
degree of cartilage loss and other bone structure parametersFig. 3. Quantiﬁcation of underlying SB parameters of each of the four regions. A total of
BV/TV; (b) SMI; (c) Tb.Th; (d) Tb.N; (e) Tb.Sp; and (f) BMD. Compared with lateral tibial sites
lower SMI and Tb.Sp. (oLT: n ¼ 50; iLT: n ¼ 50; iMT: n ¼ 38; cMT: n ¼ 36) Each bar represen
z: P ¼ 0.0114.(Supplementary Table 4). These data conﬁrm the close association
of the structural integrity of the AC and SB, and BV/TV as the key
bone structural parameter corresponding to the severity of carti-
lage pathology.Quality of the extracted RNA
All 56 RNA samples extracted from AC and SB had 28S/18S ratios
greater than 1. The RIN values were all greater than 6, which
demonstrated that high quality RNAwas isolated from both AC and
SB (Supplementary Table 5). On average,100mg of powdered tissue
yielded 2.26 mg total RNA from cartilage and 3.29 mg total RNA from
bone.Expression levels of OA genes
Gene expression for six genesdthree AC-associated genes
(COL2A1, COMP, and CRTAC1) and three SB-associated genes
(COL1A1, COL1A2, and SPP1)20e24dconﬁrmed minimal to no cross-
contamination of these tissue elements during harvest by an
experienced operator (Supplementary Fig. 2). The gene expression
(by real-time PCR normalized to GAPDH) for 61 genes was analyzedsix bone structural parameters were quantiﬁed for the four regions of interest of SB: (a)
, bone parameters from medial sites exhibited higher BV/TV, Tb.Th, Tb.N, and BMD, but
ts the mean, and error bars represent S.E.M. *: P < 0.001; #: P ¼ 0.0253; y: P ¼ 0.0069;
Fig. 4. Pearson’s correlation of OA severity of the overlying AC and structural parameters of the underlying SB. The data for all regions were combined for evaluation of the
correlation between OA severity determined by the OARSI grading system, and the six bone structure parameters. Signiﬁcant correlations were observed for OA severity and all the
bone parameters: (a) BV/TV (r ¼ 0.83); (b) SMI (r ¼ 0.7); (c) Tb.Th (r ¼ 0.75); (d) Tb.N (r ¼ 0.68); (e) Tb.Sp (r ¼ 0.7); and (f) BMD (r ¼ 0.42).
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individuals totaling 56 specimens; the mean expression pattern of
the oLT regionwas comparedwith the expression patterns in all the
other regions of interest. The 61 genes selected for analysis were
based on results of previous gene expression studies, candidate-
gene approaches, and genome-wide association studies in OA25e
37. Our novel system permitted the ﬁrst assessment of coordi-
nated gene expression in AC and site-matched SB. A total of 27 of
the 61 genes (44%) were coordinately regulated (i.e., in the same
direction with disease) in both tissues; 16 of 27 genes were coor-
dinately up-regulated, and 11 of 27 genes were coordinately down-
regulated in both tissue elements. A total of 20 of the 61 genes (33%)
were signiﬁcantly regulated only in SB (half of the 20 genes were
up-regulated and the remainder down-regulated), and 10 of the 61
genes (16%) were signiﬁcantly regulated only in AC (seven of the 10
genes were up-regulated, and three of the 10 genes were down-
regulated); very few genes (four of 61 genes) were oppositely
regulated, i.e., expression altered but in opposite directions. Rela-
tive to oLT, the site-speciﬁc changes are depicted in Fig. 5(a)
(numbers of signiﬁcantly up- or down-regulated genes), Table II
(fold changes in gene expression) and Supplementary Table 6
(exact P values in gene expression).Correlation with gene expression and severity of OA
Gene expression changes in AC and SB were correlated with
OARSI scores of OA severity and the bone structure parameter, BV/
TV (Supplementary Table 7). In one or both tissue elements, the
expression of a total of 57 of 61 genes was correlated with OARSI
scores of histological OA severity; 20 genes were signiﬁcantly
correlated both in AC and SB, 25 genes in SB only and 12 genes in AC
only [Fig. 5(b)]. The expression of a total of 58 of 61 genes was
correlated with BV/TV: 25 genes in both AC and SB, 20 genes in SB
only, and 13 genes in AC only [Fig. 5(c)]. Of the 26 genes whose
regulation was signiﬁcantly altered in both AC and SB, the expres-
sion of the majority (19) was correlated with OA severity (OARSI
score) and bone structure. [Fig. 5(d) and Table III].
Discussion
Molecular crosstalk of the cartilageeSB unit is a key component
in the pathogenesis of OA38. To the best of our knowledge, this is the
ﬁrst study to successfully extract high quality RNA from site-
matched AC and SB. The techniques described in this study repre-
sent a signiﬁcant advance over previous methods. Most previous
Fig. 5. Genes correlating with OA severity and bone structural alterations. (a) Representation of cartilage degradation, bone volume augmentation and gene involvement in the
regions of interest of the human OA knee tibia. Compared with gene expression levels of the oLT region, 30 of 61 and 40 of 61 genes showed signiﬁcant fold changes in iLT and iMT
regions in AC. Compared with gene expression levels of the oLT region, 10 of 61, 38 of 61 and 43 of 61 genes in the iLT, iMT and cMT regions showed signiﬁcant fold changes in SB.
The increasing trends in cartilage loss (OARSI score) and bone structural changes (BV/TV, %) are displayed. (b) 20 of 61 genes were signiﬁcantly regulated in both AC and SB, and
were correlated with cartilage loss. (c) 25 of 61 genes were signiﬁcantly regulated in both AC and SB, and correlated with structural alterations of the bone. (d) Venn diagram
depicting 19 genes that correlated with OA severity and bone structural abnormalities including the following: ADAM metallopeptidase with thrombospondin type 1 motif, 14
(ADAMTS14), asporin (ASPN), bone morphogenetic protein 6 (BMP6), BMP binding endothelial regulator (BMPER), chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif)
ligand 8 (CCL8), collagen, type V, alpha 1 (COL5A1), collagen, type VI, alpha 3 (COL6A3), collagen, type VII, alpha 1 (COL7A1), collagen, type XVI, alpha 1 (COL16A1), frizzled-related
protein (FRZB), growth differentiation factor 10 (GDF10), matrix metallopeptidase 3 (MMP3), osteoglycin (OGN), osteomodulin (OMD), periostin (POSTN), prostaglandin E synthase
(PTGES), tumor necrosis factor (ligand) superfamily, member 11 (TNFSF11), and wingless-type MMTV integration site family, member 1 (WNT1).
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freshly isolated cartilage, enzymatically isolated chondrocytes with
and without in vitro culture, or synovium. Hard tissues, such as
bone, become brittle when frozen; this makes them more difﬁcult
to handle, laborious and time consuming to process, and results in
inconsistent RNA quality. Thus, the majority of previous OA-related
gene expression studies have focused on AC and very little data
exist regarding OA-related gene changes in SB. As a result of
achieving high quality RNA extraction from both AC and SB, it was
feasible to analyze the gene expression of chondrocytes from the AC
and of all the cellular elements from the SB (unlike cartilage, that
has only a single cell type, the SB has a very heterogeneous
complement of cells, including osteoblasts, osteoclasts, osteocytes,
and bone marrow cells). Although the speciﬁc cell types contrib-
uting to the changes in gene expression cannot easily be conﬁrmed,
all the cell types in the SBwould be expected to contribute to the SB
gene expression proﬁle39.In addition, this method offers several advantages: RNA can be
isolated from tissues that are frozen immediately thereby avoiding
alterations in cell differentiation state and gene expression asso-
ciated with other methods; speciﬁc regions of interest can be
dissected with the bone saw; histological examination can be
performed on adjacent regions to evaluate the site-matched tissue
morphology; and the remaining specimens of bone and cartilage
can be ground at later times without compromising RNA quality
because the tissue is never thawed. This method is also applicable
to cartilage that is thinned because the depth of drill penetration
can be precisely controlled to target speciﬁc layers of the tissue.
Finally, it allows separation of the site-matched tissues. It is likely
that cross-contamination of tissues can occur, however, this can be
reduced with experience. In fact, tissue elements could be clearly
distinguished in liquid nitrogen consisting of white overlying AC
and light pink/yellow underlying SB, allowing an experienced
operator to easily divide the two tissue elements. We further
Table II
Site-speciﬁc fold changes (FC) in gene expression in AC and site-matched SB
Genes GenBank FC in overlying AC FC in underlying SB Expression
relative to oLT
iLTC iMTC iLTB iMTB cMTB AC SB
ADAMTS14 NM_139155 3.72** 6.21** 3.17*
ADAMTSL2 NM_014694 11.1** 2.35* 3.27** 2.83* 2.46**
COL5A1 NM_000093 5.90** 2.91** 2.44** 6.39**
COL6A3 NM_004369 2.76* 2.11** 5.61**
COL7A1 NM_000094 3.03* 3.23** 3.81**
CILP2 NM_153221 6.74** 2.43* 5.91* 3.77**
COMP NM_000095 4.68** 4.96** 4.07* 5.81**
FN1 NM_054034 2.85** 4.24** 2.09*
ASPN NM_017680 3.47** 2.94** 4.48** 6.86**
WNT1 NM_005430 13.9** 2.30* 3.69** 5.49**
OGN NM_033014 3.97** 5.46** 9.63** 6.21**
GDF6 NM_001001557 6.34* 8.67* 3.63*
OMD NM_005014 3.22* 3.50** 2.38** 2.60**
POSTN NM_006475 10.32* 2.51** 10.63**
PTGES NM_004878 4.11** 6.02** 1.69** 2.64** 2.57**
TNFSF11 NM_003701 5.49* 1.76** 2.41** 2.63**
BMP3 NM_001201 2.52* 2.23* 2.11**
BMP5 NM_021073 4.84** 2.63** 3.71**
BMPER NM_133468 2.15** 6.42** 2.43**
COL10A1 NM_000493 1.93** 1.92** 1.67* 2.17**
MATN4 NM_003833 6.02** 13.12** 2.33** 2.74*
MMP3 NM_002422 2.66** 5.91** 2.34* 2.15*
FRZB NM_001463 1.55* 8.13** 3.25** 7.76**
FZD4 NM_012193 1.74* 2.36** 4.95**
GDF10 NM_004962 4.45** 1.53* 3.37**
CCL2 NM_002982 2.04* 2.15* 2.56** 4.88**
CCL8 NM_005623 1.83* 2.77* 3.75** 6.54**
BMP7 NM_001719 1.72* 2.26* e
COL1A1 NM_000088 3.82* 11.03* e
COL1A2 NM_000089 3.20** 8.82* e
COL3A1 NM_000090 2.39** 7.07** e
COL5A2 NM_000393 1.87** 3.17** e
COL6A1 NM_001848 2.28* e
ECM1 NM_004425 2.93** e
DIO2 NM_013989 2.86** 6.11** e
SOST NM_025237 4.76** e
DKK3 NM_015881 1.92* 2.40** 3.19** e
ADAMTS5 NM_007038 2.06** 2.97** e
(continued on next page)
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Table II (continued )
Genes GenBank FC in overlying AC FC in underlying SB Expression
relative to oLT
iLTC iMTC iLTB iMTB cMTB AC SB
LAMA3 NM_198129 2.84** e
GDF5 NM_000557 3.94** e
IL1B NM_000576 2.27* 3.55** e
TNF NM_000594 1.84* 3.48** e
JUN NM_002228 2.32* 4.17** e
FOSB NM_006732 2.83* 4.55** e
LEP NM_000230 6.93** 17.43** e
MMP11 NM_005940 2.72** e
JUNB NM_002229 1.83* 2.94** e
ADAM12 NM_003474 2.59* 4.98** e
ADAMTS6 NM_197941 3.43** 5.13** e
COL15A1 NM_001855 2.35* 3.71** e
LOX NM_002317 2.41* 2.16* e
LOXL2 NM_002318 3.69* 4.75** e
LOXL3 NM_032603 3.13** 3.20** e
TGFBI NM_000358 3.60* 3.76** e
COL12A1 NM_004370 2.36** 3.57** e
COL9A1 NM_001851 3.34** e
IL7 NM_000880 4.31** 2.45* e
COL16A1 NM_001856 3.14** 2.68*
MMP2 NM_004530 3.36** 2.37* 3.05*
BMP6 NM_001718 3.60*
FOS NM_005252 2.03* 2.63* 6.18**
Count y 30 40 10 38 43
* ¼ P < 0.05, ** ¼ P < 0.01, ¼ gene up-regulated compared with the oLT region, ¼ gene down-regulated compared with oLT region.
Count y ¼ total number of signiﬁcantly (up or down) regulated genes.
iLTC ¼ inner lateral tibial cartilage, iMTC ¼ inner medial tibial cartilage, iLTB ¼ inner lateral tibial bone, iMTC ¼ inner medial tibial bone, cMTB ¼ central medial tibial bone.
Exact P values presented on Supplementary Table 5.
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no single gene may be considered absolutely tissue speciﬁc, taken
together, the results of all eight tissue associated genes strongly
supported the lack of cross-contamination between the tissues.
The main limitations of our study were the lack of non-OA site-
matched tissues for comparison, and the limited number of sepa-
rate subjects (eight subjects, 56 samples) that contributed to the
gene expression analyses. However, this system overcomes a major
hurdle in the ﬁelddnamely, the problem of signiﬁcant background
variation in gene expression studies; normalization to a standard-
ized histologically normal region (oLT) in each tissue controlled for
inter-individual variation and thereby enabled us to focus on
disease-related variation. Moreover, even though this represents
a small sample size, most of the OA-related genes had sufﬁcient
statistical power in our gene expression analysis; we attribute this
to the normalization strategy and to the use of microﬂuidic cards
that had high accuracy and ability to detect the gene expression for
many genes from multiple regions of one sample simultaneously.Of the 61 genes analyzed, approximately half were signiﬁcantly
changed at least two-fold compared with the relatively normal oLT
region in both SB and AC. These genes were coordinately up- (52%)
or down- (36%) regulated simultaneously, and very few genes were
regulated in opposite directions. Moreover, the level of expression
of the majority of these genes (in the iLT, iMT and cMT regions of
both tissue elements) displayed strong correlation to severity states
of the disease. However, it is possible that the differences in gene
expression from different sites could be due to an imposed loading.
Therefore, we could not differentiate the response to load from
correlation with severity state as these are inextricably linked; it is
known for instance, that in normal and disease knees that there are
consistently strong contact pressures in the iLT and cMT regions
and relatively low contact pressures in the oLT region20.
We believe that the pathways identiﬁed by the coordinately
regulated genes provide insights into disease pathogenesis and are
of interest for three main reasons: they may reveal generalizable
tissue responses in OA; they may provide insight into the signals
Table III
Genes with signiﬁcant correlation to OA severity (OARSI score) and/or bone struc-
ture (BV/TV) in overlying AC and underlying SB
Genes Site OARSI score BV/TV
Pearson r P value Pearson r P value
ADAMTS14 AC 0.7251 <0.0001 0.7855 <0.0001
SB 0.4338 0.0131 0.517 0.0024
ASPN AC 0.6562 0.0005 0.4704 0.0204
SB 0.7331 <0.0001 0.7633 <0.0001
BMP6 AC 0.4902 0.0176 0.5536 0.0061
SB 0.4327 0.0134 0.4773 0.0057
BMPER AC 0.6449 0.0009 0.8332 <0.0001
SB 0.6401 <0.0001 0.6559 <0.0001
CCL2 AC 0.4135 0.0446 0.5384 0.0097
SB 0.6466 <0.0001 0.7173 <0.0001
CCL8 AC 0.4471 0.037 0.4056 0.0493
SB 0.7005 <0.0001 0.7309 <0.0001
COL5A1 AC 0.4322 0.0349 0.4448 0.0294
SB 0.6571 <0.0001 0.7002 <0.0001
COL6A3 AC 0.606 0.0017 0.6099 0.0016
SB 0.6239 0.0001 0.6905 <0.0001
COL7A1 AC 0.5969 0.0021 0.6637 0.0004
SB 0.5947 0.0003 0.5926 0.0004
COL16A1 AC 0.5438 0.006 0.5438 0.006
SB 0.4772 0.0058 0.5439 0.0013
FRZB AC 0.6527 0.0005 0.788 <0.0001
SB 0.7958 <0.0001 0.8406 <0.0001
GDF10 AC 0.6439 0.0007 0.73 <0.0001
SB 0.7365 <0.0001 0.71 <0.0001
MMP3 AC 0.517 0.0115 0.7159 0.0001
SB 0.4027 0.0274 0.4364 0.0159
OGN AC 0.6954 0.0002 0.7016 0.0001
SB 0.5289 0.0019 0.5088 0.0029
OMD AC 0.538 0.0067 0.5801 0.003
SB 0.5209 0.0022 0.5112 0.0028
POSTN AC 0.4252 0.0383 0.5377 0.0067
SB 0.6753 <0.0001 0.7582 <0.0001
PTGES AC 0.7715 <0.0001 0.826 <0.0001
SB 0.6332 0.0001 0.6513 <0.0001
TNFSF11 AC 0.4326 0.0347 0.59 0.0024
SB 0.7519 <0.0001 0.6635 <0.0001
WNT1 AC 0.4143 0.0441 0.4333 0.0344
SB 0.5658 0.0007 0.6516 <0.0001
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identify targets whose modiﬁcation could produce beneﬁcial
effects in both AC and SB. For instance, GDF10 (also called BMP-3b),
a member of the bone morphogenetic protein (BMP) family and
the transforming growth factor-beta superfamily, has been re-
ported to be an important regulator of key events in the processes
of articular chondrocyte differentiation and bone formation40,41.
However, no prior study linked GDF10 with OA. Our data clearly
showed that GDF10 was down-regulated in both AC and SB in
association with OA severity and bone structural changes. Taken
together, these data serve to identify a potential new and prom-
ising molecular contributor to the pathogenesis of OA and
a potential new target for OA therapy.
Given the gradient of OA severity across the tibial plateau, this
model system also has the potential to provide insights into OA
pathogenesis and progression. Support for this supposition was
provided by changes in theWNT signaling gene pathway known to
be associated with OA progression42; for instance, in our model
system, a gradual up-regulation of WNT1 and down-regulation of
FRZB, a WNT1 modulator43, was evident comparing regions of
intermediate severity of disease (iLT region) to regions with more
severe disease (iMT and cMT regions).
In addition, our study identiﬁed 19 genes whose expression in
both AC and SB correlated with OA severity and bone structural
abnormalities. These 19 genes clustered into four main functional
categories: genes known to regulate chondrocyte maturation and
long bone developmente BMP6, BMPER,GDF10, FRZB,OMD, TNFSF11,and WNT144,45; genes involved in inﬂammatory responses e CCL2,
CCL8, and PTGES; genes contributing to the collagenous framework
of the ECM e ASPN, COL5A1, COL6A3, COL7A1, COL16A1, OGN, and
POSTN; and genes of the metalloproteinase family that process ECM
proteins e ADAMTS14 and MMP3. Zhang et al.46 recently reported
a whole genome microarray analysis of SB in an early experimental
OA mouse model; their reported fold changes in SB gene expression
of ASPN, CCL2, COL5A1, POSTN and TNFSF11 at the initial stages of OA
were similar to those of our study. Moreover, comparing gene
expression by microarray analysis of human OA lesional cartilage
versus intact cartilage from donors lacking macroscopic and micro-
scopic signs of OA, these same ﬁve genes were identiﬁed as differ-
entially regulated36. These results strongly support the credibility of
our methods and model system for identifying genes in AC and SB
that play a role in the pathogenesis of OA. Given evidence by Cat-
terall et al.47 suggesting that the metabolic activity of lesional
cartilage differs considerably between the hip and knee, we believe
this model system could provide insights into future studies of joint
site-speciﬁc gene regulation in the pathogenesis of OA.
In conclusion, our custom workstation made it possible to
establish a model system for evaluating alterations in gene
expressionwith OA severity representative of different stages of OA
within and between knee OA subjects. This method is not limited to
expression studies; miRNA and proteins can also be extracted from
the isolated sections of AC and SB to allow a systematic approach to
the study of OA. We believe this will provide insights into the early
pathogenic mechanisms of OA and further contribute to the
development of new therapeutic strategies.
Authors’ contributions
All authors were involved in drafting the article or revising it
critically for important intellectual content, and all authors
approved the ﬁnal version to be published. CC Wu and MTM Lee
had full access to all of the data in the study and take responsibility
for the integrity of the data and the accuracy of the data analysis.
Study conception and design: CH Chou, JY Wu, YT Chen, VB
Kraus, CC Wu, MTM Lee.
Acquisition of data: CH Chou, CH Lee, LS Lu, IW Song, HP Chuang,
SY Kuo, CC Wu.
Analysis and interpretation of data: CH Chou, VB Kraus, CC Wu,
MTM Lee.
Manuscript preparation: CH Chou, VB Kraus, CC Wu, MTM Lee.
Funding source
This study was supported by the Academia Sinica Genomic Medi-
cine Multicenter Study (40-05-GMM), the National Research
Program for Genomic Medicine, National Science Council, Taiwan
(Translational Resource Center for Genomic Medicine: NSC101-
2325-B-001-035, National Center for Genome Medicine: NSC101-
2319-B-001-001 and MTML: NSC101-2320-B-001-020-MY3), NIH/
NIA Claude D. Pepper OAIC 5P30 AG028716 and P01 AR50245
(VBK), and an OARSI Scholarship (to C-H Chou).
Conﬂict of interests
The authors declare that they have no competing interests.
Acknowledgements
The authors would like to thank Translational Resource Center
for Genomic Medicine (TRC) of National Research Program for
Biopharmaceuticals (NRPB), for the support in project management
and the Taiwan Mouse Clinic which is funded by the National
Research Program for Biopharmaceuticals (NRPB) at the National
C.-H. Chou et al. / Osteoarthritis and Cartilage 21 (2013) 450e461460Science Council (NSC) of Taiwan for technical support in micro-CT
experiment.
Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.joca.2012.11.016.
References
1. Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP. Sub-
chondral bone in osteoarthritis. Calcif Tissue Int 1991;49:20e6.
2. Goldring MB, Goldring SR. Articular cartilage and subchondral
bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci
2010;1192:230e7.
3. Herrero-Beaumont G, Roman-Blas JA, Largo R, Berenbaum F,
Castaneda S. Bone mineral density and joint cartilage: four
clinical settings of a complex relationship in osteoarthritis.
Ann Rheum Dis 2011;70:1523e5.
4. Ding C, Cicuttini F, Jones G. Tibial subchondral bone size and
knee cartilage defects: relevance to knee osteoarthritis. Oste-
oarthritis Cartilage 2007;15:479e86.
5. Kraus VB, Feng S, Wang S, White S, Ainslie M, Brett A, et al.
Trabecular morphometry by fractal signature analysis is
a novel marker of osteoarthritis progression. Arthritis Rheum
2009;60:3711e22.
6. Muraoka T, Hagino H, Okano T, Enokida M, Teshima R. Role of
subchondral bone in osteoarthritis development: a compara-
tive study of two strains of guinea pigs with and without
spontaneously occurring osteoarthritis. Arthritis Rheum
2007;56:3366e74.
7. Cox LG, van Rietbergen B, van Donkelaar CC, Ito K. Bone
structural changes in osteoarthritis as a result of mechanor-
egulated bone adaptation: a modeling approach. Osteoarthritis
Cartilage 2011;19:676e82.
8. Weinans H, Siebelt M, Agricola R, Botter SM, Piscaer TM,
Waarsing JH. Pathophysiology of peri-articular bone changes
in osteoarthritis. Bone 2012;51:190e6.
9. Burr DB. Anatomy and physiology of the mineralized tissues:
role in the pathogenesis of osteoarthrosis. Osteoarthritis
Cartilage 2004;12(Suppl A):S20e30.
10. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ.
Alteration of cartilage metabolism by cells from osteoarthritic
bone. Arthritis Rheum 1997;40:1282e91.
11. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY,
Henrotin YE. Osteoblasts from the sclerotic subchondral bone
downregulate aggrecan but upregulate metalloproteinases
expression by chondrocytes. This effect is mimicked by
interleukin-6, -1beta and oncostatin M pre-treated non-scle-
rotic osteoblasts. Osteoarthritis Cartilage 2005;13:979e87.
12. Moreau M, Rialland P, Pelletier JP, Martel-Pelletier J,
Lajeunesse D, Boileau C, et al. Tiludronate treatment improves
structural changes and symptoms of osteoarthritis in the
canine anterior cruciate ligament model. Arthritis Res Ther
2011;13:R98.
13. Walsh DA, Chapman V. Bisphosphonates for osteoarthritis.
Arthritis Res Ther 2011;13:128.
14. Castaneda S, Roman-Blas JA, Largo R, Herrero-Beaumont G.
Subchondral bone as a key target for osteoarthritis treatment.
Biochem Pharmacol 2012;83:315e23.
15. Arabelovic S, McAlindon TE. Considerations in the treatment of
early osteoarthritis. Curr Rheumatol Rep 2005;7:29e35.
16. Appleyard RC, Burkhardt D, Ghosh P, Read R, Cake M,
Swain MV, et al. Topographical analysis of the structural,
biochemical and dynamic biomechanical properties ofcartilage in an ovine model of osteoarthritis. Osteoarthritis
Cartilage 2003;11:65e77.
17. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP,
Revell PA, et al. Osteoarthritis cartilage histopathology:
grading and staging. Osteoarthritis Cartilage 2006;14:13e29.
18. Ding M, Odgaard A, Danielsen CC, Hvid I. Mutual associations
among microstructural, physical and mechanical properties of
human cancellous bone. J Bone Joint Surg Br 2002;84:900e7.
19. Ding M, Odgaard A, Hvid I. Changes in the three-dimensional
microstructure of human tibial cancellous bone in early oste-
oarthritis. J Bone Joint Surg Br 2003;85:906e12.
20. Bae JY, ParkKS, Seon JK, KwakDS, Jeon I, Song EK. Biomechanical
analysis of the effects of medial meniscectomy on degenerative
osteoarthritis. Med Biol Eng Comput 2012;50:53e60.
21. Steck E, Braun J, Pelttari K, Kadel S, Kalbacher H, Richter W.
Chondrocyte secreted CRTAC1: a glycosylated extracellular
matrix molecule of human articular cartilage. Matrix Biol
2007;26:30e41.
22. Steck E, Benz K, Lorenz H, Loew M, Gress T, Richter W. Chon-
drocyte expressed protein-68 (CEP-68), a novel human marker
gene for cultured chondrocytes. Biochem J 2001;353:169e74.
23. Parsons P, Gilbert SJ, Vaughan-Thomas A, Sorrell DA,
Notman R, Bishop M, et al. Type IX collagen interacts with
ﬁbronectin providing an important molecular bridge in artic-
ular cartilage. J Biol Chem 2011;286:34986e97.
24. Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-
Pelletier J, Pelletier JP, et al. Altered mineralization of human
osteoarthritic osteoblasts is attributable to abnormal type I
collagen production. Arthritis Rheum 2009;60:1438e50.
25. Rodriguez-Lopez J, Mustafa Z, Pombo-Suarez M, Malizos KN,
Rego I, Blanco FJ, et al. Genetic variation including non-
synonymous polymorphisms of a major aggrecanase,
ADAMTS-5, in susceptibility to osteoarthritis. Arthritis Rheum
2008;58:435e41.
26. Rodriguez-Lopez J, Pombo-Suarez M, Loughlin J, Tsezou A,
Blanco FJ, Meulenbelt I, et al. Association of a nsSNP in
ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis
Cartilage 2009;17:321e7.
27. Nakamura T, Shi D, Tzetis M, Rodriguez-Lopez J, Miyamoto Y,
Tsezou A, et al. Meta-analysis of association between the
ASPN D-repeat and osteoarthritis. Hum Mol Genet 2007;16:
1676e81.
28. Snelgrove TA, Peddle LJ, Stone C, Nofball F, Peddle D, Squire D,
et al. Association of COL1A2, COL2A1 and COL9A1 and primary
osteoarthritis in a founder population. Clin Genet 2005;67:
359e60.
29. Meulenbelt I, Min JL, Bos S, Riyazi N, Houwing-Duistermaat JJ,
van der Wijk HJ, et al. Identiﬁcation of DIO2 as a new
susceptibility locus for symptomatic osteoarthritis. Hum Mol
Genet 2008;17:1867e75.
30. Valdes AM, Evangelou E, Kerkhof HJ, Tamm A, Doherty SA,
Kisand K, et al. The GDF5 rs143383 polymorphism is associ-
ated with osteoarthritis of the knee with genome-wide
statistical signiﬁcance. Ann Rheum Dis 2011;70:873e5.
31. Loughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z,
Southam L, et al. Functional variants within the secreted
frizzled-related protein 3 gene are associated with hip oste-
oarthritis in females. Proc Natl Acad Sci U S A 2004;101:
9757e62.
32. Qin J, Shi D, Dai J, Zhu L, Tsezou A, Jiang Q. Association of the
leptin gene with knee osteoarthritis susceptibility in a Han
Chinese population: a case-control study. J Hum Genet
2010;55:704e6.
33. Aigner T, Fundel K, Saas J, Gebhard PM, Haag J, Weiss T, et al.
Large-scale gene expression proﬁling reveals major
C.-H. Chou et al. / Osteoarthritis and Cartilage 21 (2013) 450e461 461pathogenetic pathways of cartilage degeneration in osteoar-
thritis. Arthritis Rheum 2006;54:3533e44.
34. Appleton CT, Pitelka V, Henry J, Beier F. Global analyses of gene
expression in early experimental osteoarthritis. Arthritis
Rheum 2007;56:1854e68.
35. Fukui N, Miyamoto Y, Nakajima M, Ikeda Y, Hikita A,
Furukawa H, et al. Zonal gene expression of chondrocytes in
osteoarthritic cartilage. Arthritis Rheum 2008;58:3843e53.
36. Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A,
Sittinger M, et al. Genome-wide expression proﬁling reveals
new candidate genes associated with osteoarthritis. Osteoar-
thritis Cartilage 2010;18:581e92.
37. Meng J, Ma X, Ma D, Xu C. Microarray analysis of differential
gene expression in temporomandibular joint condylar carti-
lage after experimentally induced osteoarthritis. Osteoarthritis
Cartilage 2005;13:1115e25.
38. Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis.
Nat Rev Rheumatol 2011;7:43e9.
39. Kumarasinghe DD, Perilli E, Tsangari H, Truong L, Kuliwaba JS,
Hopwood B, et al. Critical molecular regulators, histomorpho-
metric indices and their correlations in the trabecular bone in
primary hip osteoarthritis. Osteoarthritis Cartilage 2010;18:
1337e44.
40. Kaihara S, Bessho K, Okubo Y, Sonobe J, Komatsu Y, Miura M,
et al. Over expression of bone morphogenetic protein-3b
(BMP-3b) using an adenoviral vector promote the osteo-
blastic differentiation in C2C12 cells and augment the boneformation induced by bone morphogenetic protein-2 (BMP-2)
in rats. Life Sci 2003;72:1683e93.
41. Lafont JE, Talma S, Hopfgarten C, Murphy CL. Hypoxia
promotes the differentiated human articular chondrocyte
phenotype through SOX9-dependent and -independent path-
ways. J Biol Chem 2008;283:4778e86.
42. Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M. Wnt signaling
antagonists are potential prognostic biomarkers for the
progression of radiographic hip osteoarthritis in elderly
Caucasian women. Arthritis Rheum 2007;56:3319e25.
43. He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, et al. Sup-
pressing Wnt signaling by the hedgehog pathway through
sFRP-1. J Biol Chem 2006;281:35598e602.
44. Zhu F, Friedman MS, Luo W, Woolf P, Hankenson KD. The
transcription factor osterix (SP7) regulates BMP6-induced
human osteoblast differentiation. J Cell Physiol 2012;227:
2677e85.
45. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins.
Growth Factors 2004;22:233e41.
46. Zhang R, Fang H, Chen Y, Shen J, Lu H, Zeng C, et al. Gene
expression analyses of subchondral bone in early experi-
mental osteoarthritis by microarray. PLoS One 2012;7:
e32356.
47. Catterall JB, Hsueh MF, Stabler TV, McCudden CR, Bolognesi M,
Zura R, et al. Protein modiﬁcation by deamidation indicates
variations in joint extracellular matrix turnover. J Biol Chem
2012;287:4640e51.
